Semaglutide vs. Tirzepatide: Which is Better for Weight Loss?
The battle of the GLP-1 agonists. We break down the clinical data from the STEP 1 and SURMOUNT-1 trials to see which medication reigns supreme.
Semaglutide
Ozempic®, Wegovy®
A pure GLP-1 receptor agonist. It mimics a hormone that targets areas of the brain that regulate appetite and food intake.
Tirzepatide
Mounjaro®, Zepbound®
A dual agonist targeting both GLP-1 and GIP receptors. This "synergistic" effect leads to potentially greater weight reduction.
The Clinical Trials: What the Data Says
To understand which is "better," we look at the pivotal clinical trials that led to their FDA approvals.
STEP 1 Trial (Semaglutide)
In the STEP 1 trial, participants taking 2.4 mg of semaglutide weekly lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% in the placebo group.
SURMOUNT-1 Trial (Tirzepatide)
The SURMOUNT-1 trial tested tirzepatide at various doses. At the highest dose (15 mg), participants achieved an average weight loss of 20.9% over 72 weeks.
Key Takeaway
While both medications are highly effective, Tirzepatide acts on two hormonal pathways instead of one, which clinical data suggests leads to greater total weight loss on average.
Side Effects: Ozempic vs Mounjaro
Both medications share similar gastrointestinal side effects, especially during the titration phase. Here's how they compare in clinical trials:
| Side Effect | Semaglutide | Tirzepatide |
|---|---|---|
| Nausea | 44% | 24-33% |
| Diarrhea | 30% | 17-23% |
| Vomiting | 24% | 9-13% |
| Constipation | 24% | 17-21% |
Key insight: While both medications cause GI side effects, tirzepatide generally shows lower rates in clinical trials. Most side effects decrease significantly after the first 4-8 weeks as your body adjusts to the medication.
Visualize the Difference
What does a 15% loss look like compared to a 21% loss? For a 200 lb person, that's a difference of 12 lbs (30 lbs vs 42 lbs lost).
Seeing the difference on your own body can help you set realistic expectations.
Frequently Asked Questions
Is Mounjaro better than Ozempic for weight loss?
Clinical trial data suggests Mounjaro (tirzepatide) produces greater weight loss than Ozempic (semaglutide). In the SURMOUNT-1 trial, patients on the highest dose of tirzepatide lost an average of 20.9% of their body weight over 72 weeks, compared to 14.9% for semaglutide in the STEP-1 trial. However, individual results vary and your doctor can help determine which is best for you.
What is the difference between semaglutide and tirzepatide?
Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist that mimics one gut hormone. Tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 receptor agonist that targets two hormonal pathways. This dual mechanism is believed to produce greater appetite suppression and more significant weight loss.
Which GLP-1 medication has fewer side effects?
Both medications share similar side effects, primarily gastrointestinal (nausea, vomiting, diarrhea, constipation). In clinical trials, nausea rates were comparable: approximately 44% for semaglutide and 24-33% for tirzepatide depending on dose. Most side effects decrease after the first few weeks of treatment.
Can you switch from Ozempic to Mounjaro?
Yes, switching from Ozempic to Mounjaro is possible under medical supervision. Your doctor will typically start you on the lowest tirzepatide dose (2.5mg) regardless of your previous semaglutide dose to minimize gastrointestinal side effects during the transition.
Which is better for belly fat: Ozempic or Mounjaro?
Both medications reduce visceral (belly) fat effectively. The SURMOUNT-1 trial showed tirzepatide produced significant reductions in waist circumference, with higher doses showing greater belly fat reduction. While no head-to-head trial has compared belly fat loss specifically, Mounjaro's greater overall weight loss suggests it may be more effective for belly fat reduction.
How much does Ozempic vs Mounjaro cost?
Without insurance, Ozempic costs approximately $900-1,000/month and Mounjaro costs $1,000-1,200/month. With insurance, copays range from $25-150/month for either. The weight-loss specific versions (Wegovy and Zepbound) may have different coverage. Check with your insurance provider for specific costs.